Check out this morning's top movers from around Wall Street, compiled by The Fly.

HIGHER - 

• Immunic (IMUX) up 46% after reporting that its lead asset, IMU-838, has demonstrated preclinical activity against severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.
• Mallinckrodt (MNK) up 7% after announcing that the FDA has accepted for review the company's new drug application for terlipressin, an investigational agent being evaluated for the treatment of hepatorenal syndrome type 1
• Expedia (EXPE) up 6% after Wall Street Journal reports the company is nearing a deal to sell a stake in itself to private equity firms Silver Lake and Apollo (APO)

UP AFTER EARNINGS -  

• AT&T (T) up 3%
• Delta Air Lines (DAL) up 2%
• Kimberly-Clark (KMB) up 1%
• Quest Diagnostics (DGX) up 2%
• Snap (SNAP) up 20%
• Teradyne (TER) up 6%
• Chipotle (CMG) up 7%

DOWN AFTER EARNINGS -

• Biogen (BIIB) down 6%
• Netflix (NFLX) down 2%
• Interactive Brokers (IBKR) down 9%

ALSO LOWER - 

• iRobot (IRBT) down 2% after JPMorgan analyst Mark Strouse downgraded shares to Underweight from Neutral with a price target of $41, down from $43